Double-Blind Placebo Controlled Trial to Evaluate the Efficacy
of Study Drug in the
Treatment of Panic Disorder.
Open-Label, Long-Term Safety Study of Transdermal Study Drug
in the Treatment of
Phase III Randomized Study Comparing 2 Doses of Intramuscular
Study Drug in Subjects with Psychosis and Acute Agitation.
Multicentre, Double-blind, Placebo-controlled, Randomised,
Fixed-dose Evaluation of the
Safety and Efficacy of Study Drug in the Long-term Prevention
of Relapse and Recurrence of
Depression and/or Mania in Patients with Bipolar I Disorder.
Multicentre, Double-blind, Double-dummy, Placebo and Lithium-controlled,
Flexible-dose Evaluation of the Safety and Efficacy of Study
Drug in the Long-term Prevention of Relapse and Recurrence
of Mania and/or Depression in Patients with Bipolar I Disorder.
Phase III Double-Blind Placebo-Controlled Study of Study Drug
in the Treatment of Psychosis with Risperidone as Active Control
Open-Label Follow-on Study of the Long-term Safety of Study
Drug in Patients with
Drug Experience with Safety and Tolerability. (Schizophrenia
and Other Psychotic
Randomized, Double-Blind, Double-Dummy, Active Placebo Controlled,
Evaluation of Study Drug compared to Study Drug on Migraine-Related
Quality of Life.
Flexible Dose Trial of Study Drug and Placebo in the Treatment
of Subjects with Panic
Enteric-Coated Study Drug Versus Daily Study Drug or Placebo
in the Continuation
Treatment of Major Depressive Disorder.